Hands down one of the lowest valued pharma co's in our stock market. The co has great visibility and cash flow generation from their business upto 2025. The company is also looking at actively growing in both pharma & agro chems.
The co has formed an excellent base and could now be seen breaking out with large volumes from the base Long at current price with stoploss below 619.
Expecting to see this co making some noise in the M&A space in FY24.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.